<DOC>
	<DOCNO>NCT02088606</DOCNO>
	<brief_summary>A prospective , multicenter , interventional study collect confirmatory evidence safety effectiveness TactiCath® percutaneous ablation catheter treatment symptomatic paroxysmal atrial fibrillation use contact force assist irrigated radiofrequency ablation .</brief_summary>
	<brief_title>TactiCath® Contact Force Ablation Catheter Study Atrial Fibrillation Continued Access Protocol</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>symptomatic PAF ( Paroxysmal Atrial Fibrillation ) refractory least one Class IIV antiarrhythmic drug minimum one document PAF episode &gt; 30 sec duration within prior 12 month minimum three PAF episodes prior 12 month 18 year old persistent longstanding persistent AF ( Atrial Fibrillation ) four cardioversions prior 12 month MI ( myocardial infarction ) , CABG ( coronary artery bypass graft ) PCI ( percutaneous coronary intervention ) within precede 3 month leave atrial diameter &gt; 5.0 cm LVEF ( leave ventricular ejection fraction ) &lt; 35 % NYHA ( New York Heart Association ) class III IV previous leave atrial ablation procedure previous tricuspid mitral valve repair surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
</DOC>